REVBW NASDAQ
Revelation Biosciences, Inc.
1W: +10.0%
1M: -42.1%
3M: -54.2%
YTD: -32.1%
1Y: -71.3%
3Y: -70.7%
5Y: -99.0%
$0.01
+0.00 (+1.85%)
Weekly Expected Move ±66.7%
$-0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$27K
+3.1% ▲
Operating Income
-$9M
-13.7% ▼
Net Income
-$9M
+40.7% ▲
EPS (Diluted)
$-23.95
+72.7% ▲
EBITDA
-$9M
-13.8% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $27K |
| Gross Profit | $0 | $0 | $0 | $0 | -$27K |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $7M | $5M | $4M | $4M | $4M |
| SG&A Expenses | $5M | $5M | $5M | $4M | $5M |
| Operating Expenses | $12M | $11M | $9M | $8M | $9M |
| Operating Income | -$12M | -$11M | -$9M | -$8M | -$9M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $42K | $0 | $0 | $0 | $0 |
| Income Before Tax | -$12M | -$11M | -$120K | -$15M | -$9M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$12M | -$11M | -$120K | -$15M | -$9M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-20400.00 | $-9643.37 | $-8.41 | $-87.68 | $-23.95 |
| EBITDA | -$12M | -$11M | -$9M | -$8M | -$9M |
| Shares Outstanding | 588 | 1123 | 14290 | 171510 | 6M |